Pediatric acute and surgical pain management: Recent advances and future perspectives

International Anesthesiology Clinics

Volumn 50, Issue 4, 2012, Pages 66-82

  Chidambaran, Vidya ^a   Sadhasivam, Senthilkumar ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; PARACETAMOL;

ANALGESIA; CHILD HEALTH; HUMAN; NEUROBIOLOGY; NEUROTOXICITY; PAIN; PAIN ASSESSMENT; PHARMACOGENOMICS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW;

ACUTE PAIN; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; CHILD; HUMANS; PAIN, POSTOPERATIVE; PHARMACOGENETICS;

EID: 84867728476     PISSN: 00205907     EISSN: 15371913     Source Type: Journal    
DOI: 10.1097/AIA.0b013e31826f3284     Document Type: Review

References (74)

1. Tripp DA, Stanish WD, Reardon G, et al. Comparing postoperative pain experiences of the adolescent and adult athlete after anterior cruciate ligament surgery. J Athl Train. 2003;38:154-157.
2. Verghese ST, Hannallah RS. Acute pain management in children. J Pain Res. 2010;3:105-123.
3. Taylor EM, Boyer K, Campbell FA. Pain in hospitalized children: a prospective crosssectional survey of pain prevalence, intensity, assessment and management in a Canadian pediatric teaching hospital. Pain Res Manag. 2008;13:25-32.
4. Nelson KL, Yaster M, Kost-Byerly S, et al. A national survey of American Pediatric Anesthesiologists: patient-controlled analgesia and other intravenous opioid therapies in pediatric acute pain management. Anesth Analg. 2010;110:754-760.
5. McDonald AJ, Cooper MG. Patient-controlled analgesia: an appropriate method of pain control in children. Paediatr Drugs. 2001;3:273-284.
6. Monitto CL, Greenberg RS, Kost-Byerly S, et al. The safety and efficacy of parent-/nurse-controlled analgesia in patients less than six years of age. Anesth Analg. 2000;91:573-579.
7. Yildiz K, Tercan E, Dogru K, et al. Comparison of patient-controlled analgesia with and without a background infusion after appendicectomy in children. Paediatr Anaesth. 2003;13:427-431.
8. Peters JW, Bandell Hoekstra IE, Huijer Abu-Saad H, et al. Patient controlled analgesia in children and adolescents: a randomized controlled trial. Paediatr Anaesth. 1999;9:235-241.
9. Stubhaug A, Breivik H. Prevention and treatment of hyperalgesia and persistent pain after surgery. Pain, Best Practice and Research Compendium, Elsevier 2007;281-288.
10. Senturk M, Ozcan PE, Talu GK, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg. 2002;94:11-15.
11. Wong GT, Yuen VM, Chow BF, et al. Persistent pain in patients following scoliosis surgery. Eur Spine J. 2007;16:1551-1556.
12. Butkovic D, Kralik S, Matolic M, et al. Postoperative analgesia with intravenous fentanyl PCA vs epidural block after thoracoscopic pectus excavatum repair in children. Br J Anaesth. 2007;98:677-681.
13. Soliman IE, Apuya JS, Fertal KM, et al. Intravenous versus epidural analgesia after surgical repair of pectus excavatum. Am J Ther. 2009;16:398-403.
14. Izwaryn U. Bilateral intrapleural analgesia with 0.375% bupivacaine as a routine therapy after Nuss procedure for pecus excavatum in children. Rev Pediatr Surg. 2006;1:145-152.
15. Taenzer AH, Clark C. Efficacy of postoperative epidural analgesia in adolescent scoliosis surgery: a meta-analysis. Paediatr Anaesth. 2010;20:135-143.
16. Sharma S, Balireddy RK, Vorenkamp KE, et al. Beyond opioid patient-controlled analgesia: a systematic review of analgesia after major spine surgery. Reg Anesth Pain Med. 2012;37:79-98.
17. Maxwell LG, Kaufmann SC, Bitzer S, et al. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study. Anesth Analg. 2005;100:953-958.
18. Licup N, Baumrucker SJ. Methylnaltrexone: treatment for opioid-induced constipation. Am J Hosp Palliat Care. 2011;28:59-61.
19. Buchler MW, Seiler CM, Monson JR, et al. Clinical trial: alvimopan for the management of postoperative ileus after abdominal surgery: results of an international randomised, double-blind, multicentre, placebo-controlled clinical study. Aliment Pharmacol Ther. 2008;28:312-325.
20. Moffett BS, Wann TI, Carberry KE, et al. Safety of ketorolac in neonates and infants after cardiac surgery. Paediatr Anaesth. 2006;16:424-428.
21. Aldrink JH, Ma M, Wang W, et al. Safety of ketorolac in surgical neonates and infants 0 to 3 months old. J Pediatr Surg. 2011;46:1081-1085.
22. Hong JY, Won Han S, Kim WO, et al. Fentanyl sparing effects of combined ketorolac and acetaminophen for outpatient inguinal hernia repair in children. J Urol. 2010;183:1551-1555.
23. Dart RC, Rumack BH. Intravenous acetaminophen in the United States: iatrogenic dosing errors. Pediatrics. 2012;129:349-353.
24. Marret E, Rolin M, Beaussier M, et al. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg. 2008;95:1331-1338.
25. Massey GV, Pedigo S, Dunn NL, et al. Continuous lidocaine infusion for the relief of refractory malignant pain in a terminally ill pediatric cancer patient. J Pediatr Hematol Oncol. 2002;24:566-568.
26. Giannakoulopoulos X, Teixeira J, Fisk N, et al. Human fetal and maternal noradrenaline responses to invasive procedures. Pediatr Res. 1999;45:494-499.
27. Fisk NM, Gitau R, Teixeira JM, et al. Effect of direct fetal opioid analgesia on fetal hormonal and hemodynamic stress response to intrauterine needling. Anesthesiology. 2001;95:828-835.
28. Lee SJ, Ralston HJ, Drey EA, et al. Fetal pain: a systematic multidisciplinary review of the evidence. JAMA. 2005;294:947-954.
29. Brusseau R. Developmental perspectives: is the fetus conscious? Int Anesthesiol Clin. 2008;46:11-23.
30. Anand KJ, Aranda JV, Berde CB, et al. Summary proceedings from the neonatal pain-control group. Pediatrics. 2006;117:S9-S22.
31. Fitzgerald M, Walker SM. Infant pain management: a developmental neurobiological approach. Nature Clin Pract Neurol. 2009;5:35-50.
32. Beggs S, Currie G, Salter MW, et al. Priming of adult pain responses by neonatal pain experience: maintenance by central neuroimmune activity. Brain. 2012;135:404-417.
33. Anand KJ, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet. 1987;1:243-248.
34. Taddio A, Katz J, Ilersich AL, et al. Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet. 1997;349:599-603.
35. Boat AC, Sadhasivam S, Loepke AW, et al. Outcome for the extremely premature neonate: how far do we push the edge? Paediatr Anaesth. 2011;21:765-770.
36. Handelmann GE, Dow-Edwards D. Modulation of brain development by morphine: effects on central motor systems and behavior. Peptides. 1985;6(suppl 2):29-34.
37. Sargeant TJ, Day DJ, Miller JH, et al. Acute in utero morphine exposure slows G2/M phase transition in radial glial and basal progenitor cells in the dorsal telencephalon of the E15.5 embryonic mouse. Eur J Neurosci. 2008;28:1060-1067.
38. Hu S, Sheng WS, Lokensgard JR, et al. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology. 2002;42:829-836.
39. Mess B, Ruzsas C, Hayashi S. Impaired thyroid function provoked by neonatal treatment with drugs affecting the maturation of monoaminergic and opioidergic neurons. Exp Clin Endocrinol. 1989;94:73-81.
40. MacGregor R, Evans D, Sugden D, et al. Outcome at 5-6 years of prematurely born children who received morphine as neonates. Arch Dis Child Fetal Neonatal Ed. 1998;79:F40-F43.
41. de Graaf J, van Lingen RA, Simons SH, et al. Long-term effects of routine morphine infusion in mechanically ventilated neonates on children's functioning: five-year follow-up of a randomized controlled trial. Pain. 2011;152:1391-1397.
42. Sanders RD, Sun P, Patel S, et al. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand. 2010;54:710-716.
43. Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204:e1-e11.
44. Holliday R. Mechanisms for the control of gene activity during development. Biol Rev Camb Philos Soc. 1990;65:431-471.
45. Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol. 2009;49:243-263.
46. Chidambaran V, Ngamprasertwong P, Vinks AA, et al. Pharmacogenetics and anesthetic drugs. Curr Clin Pharmacol. 2012;7:78-101.
47. Sadhasivam S, Chidambaran V, Ngamprasertwong P, et al. Race and unequal burden of perioperative pain and opioid related adverse effects in children. Pediatrics. 2012;129:832-838.
48. Sadhasivam S, Krekels E, Chidambaran V, et al. Morphine clearance in children: does race or genetics matter? J Opioid Manag. 2012;8:217-226.
49. Patten CJ, Thomas PE, Guy RL, et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol. 1993;6:511-518.
50. Murray GI, Foster CO, Barnes TS, et al. Cytochrome P450IA expression in adult and fetal human liver. Carcinogenesis. 1992;13:165-169.
51. Kearns GL, Leeder JS, Wasserman GS. Acetaminophen intoxication during treatment: what you don't know can hurt you. Clin Pediatr (Phila). 2000;39:133-144.
52. Kumpulainen E, Kokki H, Laisalmi M, et al. How readily does ketorolac penetrate cerebrospinal fluid in children? J Clin Pharmacol. 2008;48:495-501.
53. Gupta A, Cheng J, Wang S, et al. Analgesic efficacy of ketorolac and morphine in neonatal rats. Pharmacol Biochem Behav. 2001;68:635-640.
54. Ririe DG, Prout HD, Barclay D, et al. Developmental differences in spinal cyclooxygenase 1 expression after surgical incision. Anesthesiology. 2006;104: 426-431.
55. Girard H, Court MH, Bernard O, et al. Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics. 2004;14:501-515.
56. US Food and Drug Administration. Table on Pharmacogenomic Biomarkers in Drug Labels. http://www.fda.gov/drugs/scienceresearch/researchareas/ pharmacogenetics/ucm083378.htm. US Food and Drug Administration; Accessed September 3, 2012.
57. Eap CB, Bochud M, Elston RC, et al. CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt. Hypertension. 2007;49:1007-1014.
58. Bunten H, Liang WJ, Pounder DJ, et al. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths. Clin Pharmacol Ther. 2010;88:383-389.
59. Koren G, Cairns J, Chitayat D, et al. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet. 2006;368:704.
60. Ciszkowski C, Madadi P, Phillips MS, et al. Codeine, ultrarapid- metabolism genotype, and postoperative death. N Engl J Med. 2009;361:827-828.
61. Kelly LE, Rieder M, van den Anker J, et al. More codeine fatalities after tonsillectomy in North American children. Pediatrics. 2012;129:e1343-e1347.
62. Stamer UM, Lehnen K, Hothker F, et al. Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain. 2003;105:231-238.
63. Wang G, Zhang H, He F, et al. Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population. Eur J Clin Pharmacol. 2006;62:927-931.
64. Chou WY, Wang CH, Liu PH, et al. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology. 2006;105:334-337.
65. Janicki PK, Schuler G, Francis D, et al. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. Anesth Analg. 2006;103:1011-1017.
66. Sia AT, Lim Y, Lim EC, et al. A118G single nucleotide polymorphism of human muopioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008;109:520-526.
67. Fukuda K, Hayashida M, Ide S, et al. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain. 2009;147:194-201.
68. Bessler H, Shavit Y, Mayburd E, et al. Postoperative pain, morphine consumption, and genetic polymorphism of IL-1beta and IL-1 receptor antagonist. Neurosci Lett. 2006;404:154-158.
69. Candiotti KA, Yang Z, Morris R, et al. Polymorphism in the interleukin-1 receptor antagonist gene is associated with serum interleukin-1 receptor antagonist concentrations and postoperative opioid consumption. Anesthesiology. 2011;114:1162-1168.
70. Diatchenko L, Nackley AG, Slade GD, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain. 2006;125:216-224.
71. Mogil JS, Wilson SG, Chesler EJ, et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci USA. 2003;100:4867-4872.
72. Fujita KI, Ando Y, Yamamoto W, et al. Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer. Cancer Chemother Pharmacol. 2010;65:251-288.
73. Campa D, Gioia A, Tomei A, et al. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther. 2008;83:559-566.
74. Lotsch J, Geisslinger G. Current evidence for a genetic modulation of the response to analgesics. Pain. 2006;121:1-5.